# Second Study of the Effect of Teriparatide on Hip Fracture Healing

> **NCT01473602** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 39 (actual)

## Conditions studied

- Femur Neck Fracture

## Interventions

- **DRUG:** Teriparatide
- **DRUG:** Placebo
- **DIETARY_SUPPLEMENT:** Calcium supplementation
- **DIETARY_SUPPLEMENT:** Vitamin D supplementation

## Key facts

- **NCT ID:** NCT01473602
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2015-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01473602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01473602, "Second Study of the Effect of Teriparatide on Hip Fracture Healing". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01473602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*